Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Athenex and Beijing Sciecure Pharmaceutical announce binding agreement to launch and market five injectable pharmaceutical products in North America
2016-10-25 22:24
ADI-PEG 20 Can Boost Anti-Tumor Immune Surveillance
2016-10-25 03:55
MicuRx Initiates Phase 3 Clinical Trial for MRX-I, A New Potent Oral Antibiotic Against Gram-positive Bacteria, Including MRSA
2016-10-20 08:00
First Patient in Malaysia Receives TheraSphere™ radioembolisation Therapy
2016-10-19 07:30
Athenex announces Xiangxue Pharmaceuticals Company Limited, its KX-02 development partner in China, has achieved a regulatory milestone in that territory
2016-10-18 23:23
Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies
2016-10-17 14:00
CHMP Adopts Positive Opinion of Metformin, Including Merck's Type 2 Diabetes Treatment Portfolio, in Patients with Renal Impairment
2016-10-14 22:53
Allergan's BELKYRA® (Deoxycholic Acid) Receives Marketing Authorisation In Sweden For The Treatment Of Moderate To Severe Fullness Under The Chin (Double Chin)
2016-10-13 19:00
Daiichi Sankyo Announces "TaNeDS Europe 2017" Collaborative Drug Discovery Programme
2016-10-12 09:00
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA)
2016-10-11 16:00
Jubilant Pharma Completes the Issuance of US$ 300 Mn 5-year Unsecured High Yield Bonds
2016-10-07 15:52
Tillotts Pharma AG's Parent Company Zeria Pharmaceutical Receives Approval for Zentacort(R) 3mg Capsules in Japan
2016-10-06 20:09
Merck Unveils New State-of-the-Art M Lab(TM) Collaboration Center in Korea
2016-10-06 12:00
DSM Highlights Global Vitamin C Deficiencies at KAVITA International Seminar
2016-10-06 09:47
Merck's Udit Batra Receives 'CEO of the Year' Award from CPhI Pharma
2016-10-05 14:00
Frost & Sullivan Applauds argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPLE Antibody(TM)
2016-10-05 14:00
Multisorb Announces Hyderabad Manufacturing Site to Support Indian Pharmaceutical Industry
2016-10-05 02:55
Acquisition of the Thomson Reuters Intellectual Property and Science Business by Onex and Baring Asia Completed
2016-10-04 04:35
AbbVie Opens First Phase of its Global Manufacturing Facility in Singapore to Support the Growth of its Pipeline
2016-09-29 10:00
Additional Interim Data Supporting Long-Term Use of Vedolizumab in Patients with Ulcerative Colitis and Crohn's Disease Published in Journal of Crohn's and Colitis
2016-09-29 03:49
1
383
384
385
386
387
412